Michael D Privitera , MD

Medical Degree: SUNY Upstate Medical University Syracuse, NY,

Bachelor of Arts: The Johns Hopkins University Baltimore, 1976 (Biology)

Residency: Georgetown University Washington, DC, 1984 (Neurology)

Fellowship: University of Texas Southwestern Medical Center Dallas, TX, 1986 (Clinical Neurophysiology in Epilepsy)

American Board of Psychiatry and Neurology (Epilepsy) (Certification Date: 08-11-2014 )

American Board of Psychiatry and Neurology (Neurology) (Certification Date: 04-30-1987 )

Clinical Neuropsychology

Epilepsy

Neurology

Absence Seizures (Petit Mal Seizures)

Anti-Epileptic Drug Toxicity

Atonic Seizures

Clonic seizures

Complex Partial Seizure

Epilepsia Partialis Continua

Epilepsy in Pregnancy

Epilepsy-Related Cognitive Dysfunction

Febrile Seizure

Focal Seizures

Frontal Lobe Seizures

Generalized Epilepsy

Generalized Seizure

Genetic Epilepsy

Grand Mal Seizures

Juvenile Myoclonic Epilepsy

Landau-Kleffner Syndrome

Myoclonic Seizures

Myoclonus

Nonconvulsive Status Epilepticus

Partial Motor Epilepsy

Partial Seizure

Partial Sensory Epilepsy

Post-Traumatic Epilepsy

Progressive Myoclonic Epilepsies

Psychogenic Seizure

Referred Pain

Reflex Epilepsy

Rolandic Epilepsy

Seizure Disorders

Seizures

Severe Seizures

Status Epilepticus

Temporal Lobe Seizure

Tonic Seizures

Tonic-Clonic Seizure (Grand mal seizure)

Unverricht-Lundborg Syndrome

Epilepsy

Neurology

Epilepsy; Antiepileptic Drug Pharmacology and Kinetics; Antiepileptic Drug Development; Clinical Trials; Surgical Treatment of Epilepsy; Epilepsy Genetics; Seizure Disorders; Electroencephalogram (EEG)

- Jan/1987-Aug/1993 Assistant Professor, Department of Neurology, University of Cincinnati College of Medicine ,

- Sept/1993-Aug/1998 Associate Professor (with tenure), Department of Neurology, University of Cincinnati College of Medicine ,

- Jan/1993-1998 Consultant, Jewish Hospital, Cincinnati, OH,

- Jan/1987-Oct/2002 Director of EEG Laboratory and Epilepsy Monitoring Unit, University Hospital (accredited by American EEG Society, 1993) ,

- Jan/1987-2003 Director, Clinical Neurophysiology/Epilepsy Fellowship Program (accredited by American Board Psychiatry and Neurology, 1997) ,

- Apr/2003-July/2004 Assistant Dean Practice Plan, University of Cincinnati Medical Center,

- Jan/1997-present Consultant in Neurology, The Christ Hospital,

- Jan/1987-present Consultant in Neurology, VA Medical Center, Cincinnati, OH ,

- Jan/1987-present Director, Cincinnati Epilepsy Center,

- Jul/1993-present Consultant, Cincinnati Children’s Hospital, Cincinnati, OH,

- Sep/1998-present Professor (with tenure), Department of Neurology,

- Sep/2000-June 2008 Medical Director and Chair of Clinical Practice and Research Committees, UC Physicians,

- Apr/2000-Jan 2008 Vice-President, University Neurology, Inc.,

- Apr/2000-Jan 2008 Vice-Chair, Administrative and Clinical, Department of Neurology,

- Oct 2004-present Clinical Leadership Council of University Hospital,

- Jan 2005–2006 Interim Director of Waddell MS Center, University of Cincinnati,

- Jan 2005-2008 Board of Trustees of the American Epilepsy Society,

- July 2008- present Treasurer, American Epilepsy Society,

2000 to present Co-Investigator: Quality of Life in Newly Diagnosed Epilepsy and Seizures. Mentored Patient-Oriented Research Career Development Award (K23), National Institutes of Health.

2000 to present Site Principal Investigator: Neurodevelopment Effects of Antiepileptic Drugs. National Institutes of Health.

2002 to present Co-Investigator: Talampanel as adjunctive therapy in patients with partial seizures. Ivax Laboratories.

2003 to present Principal Investigator: SP615: An open-label extension trial to determine the tolerability and efficacy of long-term oral SPM 927 as adjunctive therapy in patients with partial seizures. Schwarz Pharma.

2005 – present An open-label extension trial to determine safety and efficacy of long-term oral SPM 927 in patients with partial seizures.

2006 to present Co-Investigator: Linking serotonin function in MDMA users by concurrent EEG and fMRI (NIH K01)

2006 to present Co-Mentor: EEG-fMRI in patients with JME (NIH K23 NS052468). Mentored Patient-Oriented Research Career Development Award (K23), National Institutes of Health. Award period: 7/1/06-6/30/11; Budget $875,552

2007-present Co-Investigator A international, double-blind, parallel-group, placebo-controlled, randomized study: evaluation of the efficacy and safety of brivaracetam in subjects (≥ 16 to 70 years old_ with Partial Onset Seizures PI David Ficker, MD

2008 – present Co-Investigator: An open-label multicenter, follow-up trial to evaluate the long-term safety and efficacy of brivaracetam used as adjunctive treatment at a flexible dose up to a maximum of 150 mg/day in subjects aged 16 years or older suffering from epilepsy PI David Ficker, MD

2008 - present A double-blind, placebo-controlled, dose-escalation, parallel-group study to evaluate the efficacy and safety of E207 (perampanel) given as adjunctive therapy in subjects with refractory partial seizures (Eisai Clinical Study Protocol E2007-G000-304)

2008- present A 14-month open-label extension phase of the double-blind, placebo-controlled, dose-escalation, parallel-group studies to evaluate the efficacy and safety of E2007 (perampanel) given as adjunctive therapy in subjects with refractory partial seizures (Eisai Clinical Study Protocol E2007-G000-307)

2008- present Co-Investigator: Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam (0.25, 0.5 and 1.0 mg/kg/day) in Patients with Lennox-Gastaut Syndrome, UCB $60,150. PI: David Ficker, M.D.

2008 - Present Co-Investigator: Safety and Effectiveness of Open-Label Clobazam in Subjects with Lennox-Gastaut Syndrome. PI: David Ficker, M.D.

Grant: #SRS 001803 Investigators:Privitera, Michael 07-01-2005 -06-30-2008 American Epilepsy Society, Inc. A Multicenter Consortium to Plan and Execute a Randomized Clinical Trial Exploring Medication Resistance in Newly Diagnosed Epilepsy Role:PI $60,000.00 Active Level:Private Non-Profit

Grant: #R01 NS038455 Investigators:Privitera, Michael 09-01-2005 -08-31-2010 National Institute of Neurological Disorders and Stroke Neurodevelopment Effects of Antiepileptic Drugs in Humans (NEAD II) Role:PI $251,258.80 Active Level:Federal

Grant: #1-R01-NS-40396-03-A0-S1-E0 Investigators:Privitera, Michael 01-01-2004 -12-31-2004 National Institute of Neurological Disorders and Stroke Genetic Influences on Human Epilepsy Role:PI $30,500.00 Closed Level:Federal

Grant: #5-R01-NS-38455-05-A0-S0-E0 Investigators:Privitera, Michael 09-30-2000 -08-31-2005 National Institute of Neurological Disorders and Stroke Neurodevelopment Effects of Antiepileptic Drugs in Humans Role:PI $135,346.00 Closed Level:Federal

Investigators:Privitera, Michael 01-01-2002 -12-07-2002 University of Cincinnati Neuroscience Institute Blood Genomics of Seisures & Syncope Role:PI $20,000.00 Closed Level:Industry

Grant: #5-N01-NS-72374-03-A0-S0-E0 Investigators:Privitera, Michael 08-01-1997 -10-31-1999 National Institute of Neurological Disorders and Stroke Losigamone as Monotherapy in the Treatment of Complex Partial Seizures Role:PI $298,649.00 Closed Level:Federal

Grant: #SRS 006284 Investigators:Privitera, Michael 06-01-2008 -08-31-2009 National Institute of Neurological Disorders and Stroke Progesterone Therapy for Women with Epilepsy Role:PI $3,642.00 Active Level:Federal

Grant: #INTREPID - 2566 Study / W81XWH-09-1-0496 Investigators:Privitera, Michael; Szaflarski, Jerzy 04-01-2011 -03-31-2013 Department of Defense A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NNZ-2566 in Patients with Traumatic Brain Injury (TBI) ... (INTREPID-2566 Study) Role:PI $336,852.00 Active Level:Federal

Grant: #SRS 007808 Investigators:Privitera, Michael 09-16-2011 -09-15-2014 Food and Drug Administration EQUIGEN Generic Equivalence Trials Role:PI $1,595,332.00 Active Level:Federal

Grant: #Fellowship - Bonner Investigators:Bonner, Shawna; Privitera, Michael; Shear, Paula 08-01-2012 -10-31-2012 Epilepsy Foundation Social Cognition and Psychosocial Functioning in Temporal Lobe Epilepsy Role:Collaborator $3,000.00 Closed Level:Private Non-Profit

Grant: #S980286 \ NS038455 Investigators:Flood-Shaffer, Kellie; Privitera, Michael 08-01-2012 -07-31-2017 National Institute of Neurological Disorders and Stroke Maternal Outcomes and Neurodevelopment Effects of Antiepileptic Drugs (MONEAD) Role:PI $80,963.00 Awarded Level:Federal

Grant: #134275 / 5R01NS035929 Investigators:Privitera, Michael 01-01-2014 -12-31-2014 National Institute of Neurological Disorders and Stroke Presurgical Applications of FMRI in Epilepsy Role:PI $10,965.63 Active Level:Federal

Grant: #ECHO sub CDC 1NU58DP006256-02-00 Investigators:Privitera, Michael 06-01-2018 -05-31-2019 Centers for Disease Control and Prevention Project ECHO Role:PI $100,000.00 Awarded Level:Federal

Grant: #S02583-01 / 5 U48 DP006389-02 Investigators:Privitera, Michael 08-01-2021 -09-29-2021 Centers for Disease Control and Prevention University of Iowa Prevention Research Center for Rural Health Role:PI 0.00 Hold Level:Federal

Grant: #Project ECHO - New 5 year segment Investigators:Privitera, Michael 09-30-2021 -09-29-2026 Centers for Disease Control and Prevention Project ECHO - New 5 year segment Role:PI 116114.40 Hold Level:Federal

Investigators:Privitera, Michael 01-28-2022 -01-27-2025 Neurelis An Exploratory Open-Label Study of the Effects on Responsive Neurostimulator EEG Epileptiform Activity After Intranasal Administration of a Single Dose of Valtoco to People with Epilepsy... Role:PI 181124.21 Hold Level:Industry

Grant: #EQU-202 12-01-2022 -11-30-2025 Medpace Inc. A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures Role:PI 0.00 Hold Level:Industry

Grant: #EQU-202 12-01-2022 -11-30-2025 Medpace Inc. A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures Role:PI 0.00 Hold Level:Industry

Grant: #pending Investigators:Privitera, Michael 09-30-2023 -09-29-2024 Centers for Disease Control and Prevention Expanding epilepsy self-management support in healthcare networks (EXPAND) Role:PI 849280.11 Hold Level:Federal

12-19-2023 -12-19-2026 Neurava Inc. A novel wearable system for monitoring and alerting for seizures and cardiorespiratory dysfunctions Role:PI 92268.99 Hold Level:Industry

12-19-2023 -12-19-2026 Neurava Inc. A novel wearable system for monitoring and alerting for seizures and cardiorespiratory dysfunctions Role:PI 92268.99 Hold Level:Industry

Grant: #BHV7000-302 03-04-2024 -03-05-2027 Biohaven Therapeutics, Ltd. A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy Role:PI 228327.36 Hold Level:Industry

Grant: #BHV7000-302 03-04-2024 -03-05-2027 Biohaven Therapeutics, Ltd. A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy Role:PI 228327.36 Hold Level:Industry

Peer Reviewed Publications

Buelow,J. M., Privitera,M., Levisohn,P., Barkley,G. L. (2009. ) A description of current practice in epilepsy monitoring units .Epilepsy & behavior : E&B, , 15 (3 ) ,308 -313

McNally,K. A., Schefft,B. K., Szaflarski,J. P., Howe,S. R., Yeh,H. S., Privitera,M. D. (2009. ) Application of signal detection theory to verbal memory testing to distinguish patients with psychogenic nonepileptic seizures from patients with epileptic seizures .Epilepsy & behavior : E&B, , 14 (4 ) ,597 -603

Meador,K. J., Baker,G. A., Browning,N., Clayton-Smith,J., Combs-Cantrell,D. T., Cohen,M., Kalayjian,L. A., Kanner,A., Liporace,J. D., Pennell,P. B., Privitera,M., Loring,D. W., NEAD Study Group (2009. ) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs .The New England journal of medicine, , 360 (16 ) ,1597 -1605

Incorpora,G., Pavone,P., Cocuzza,M., Privitera,M., Pavone,L., Ruggieri,M. (2009. ) Neonatal onset of bath-induced alternating hemiplegia of childhood .European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, ,

Potter,J. L., Schefft,B. K., Beebe,D. W., Howe,S. R., Yeh,H. S., Privitera,M. D. (2009. ) Presurgical neuropsychological testing predicts cognitive and seizure outcomes after anterior temporal lobectomy .Epilepsy & behavior : E&B, , 16 (2 ) ,246 -253

Fargo,J. D., Schefft,B. K., Szaflarski,J. P., Howe,S. R., Yeh,H. S., Privitera,M. D. (2008. ) Accuracy of clinical neuropsychological versus statistical prediction in the classification of seizure types .The Clinical neuropsychologist, , 22 (2 ) ,181 -194

Szaflarski,J. P., Holland,S. K., Jacola,L. M., Lindsell,C., Privitera,M. D., Szaflarski,M. (2008. ) Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy .Epilepsy & behavior : E&B, , 12 (1 ) ,74 -83

Privitera,M. D. (2008. ) Generic antiepileptic drugs: current controversies and future directions .Epilepsy currents / American Epilepsy Society, , 8 (5 ) ,113 -117

Ramirez,M. J., Schefft,B. K., Howe,S. R., Hwa-Shain,Y., Privitera,M. D. (2008. ) Interictal and postictal language testing accurately lateralizes language dominant temporal lobe complex partial seizures .Epilepsia, , 49 (1 ) ,22 -32

Vannest,J., Szaflarski,J. P., Privitera,M. D., Schefft,B. K., Holland,S. K. (2008. ) Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy .Epilepsy & behavior : E&B, , 12 (3 ) ,410 -418

Incorpora,G., Pavone,P., Ruggieri,M., Cocuzza,M., Mazzone,L., Parano,E., Privitera,M. (2008. ) Neonatal onset of hot water reflex seizures in monozygotic twins subsequently manifesting episodes of alternating hemiplegia .Epilepsy research, , 78 (2-3 ) ,225 -231

Griffith,N. M., Smith,K. M., Schefft,B. K., Szaflarski,J. P., Privitera,M. D. (2008. ) Optimism, pessimism, and neuropsychological performance across semiology-based subtypes of psychogenic nonepileptic seizures .Epilepsy & behavior : E&B, , 13 (3 ) ,478 -484

Schefft,B. K., Dulay,M. F., Fargo,J. D., Szaflarski,J. P., Yeh,H. S., Privitera,M. D. (2008. ) The use of self-generation procedures facilitates verbal memory in individuals with seizure disorders .Epilepsy & behavior : E&B, , 13 (1 ) ,162 -168

Szaflarski,J. P., Meckler,J. M., Szaflarski,M., Shutter,L. A., Privitera,M. D., Yates,S. L. (2007. ) Levetiracetam use in critically ill patients .Neurocritical care, , 7 (2 ) ,140 -147

Testa,S. M., Schefft,B. K., Szaflarski,J. P., Yeh,H. S., Privitera,M. D. (2007. ) Mood, personality, and health-related quality of life in epileptic and psychogenic seizure disorders .Epilepsia, , 48 (5 ) ,973 -982

Griffith,N. M., Szaflarski,J. P., Schefft,B. K., Isaradisaikul,D., Meckler,J. M., McNally,K. A., Privitera,M. D. (2007. ) Relationship between semiology of psychogenic nonepileptic seizures and Minnesota Multiphasic Personality Inventory profile .Epilepsy & behavior : E&B, , 11 (1 ) ,105 -111

Fargo,J. D., Schefft,B. K., Kent,G. P., Szaflarski,J. P., Privitera,M. D., Yeh,H. S. (2007. ) The prevalence of seizure types among individuals referred for phase I neuropsychological assessment: demographic and neuropsychological characteristics .The Clinical neuropsychologist, , 21 (3 ) ,442 -455

Chadwick,D., Privitera,M. (2006. ) How skeptical should we be about industry-sponsored studies? .Neurology, , 67 (3 ) ,378 -379

Privitera,M. (2006. ) Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry .Epilepsy research, , 68 (1 ) ,52 -56

Szaflarski,M., Meckler,J. M., Privitera,M. D., Szaflarski,J. P. (2006. ) Quality of life in medication-resistant epilepsy: the effects of patient';s age, age at seizure onset, and disease duration .Epilepsy & behavior : E&B, , 8 (3 ) ,547 -551

Szaflarski,M., Szaflarski,J. P., Privitera,M. D., Ficker,D. M., Horner,R. D. (2006. ) Racial/ethnic disparities in the treatment of epilepsy: what do we know? What do we need to know? .Epilepsy & behavior : E&B, , 9 (2 ) ,243 -264

Welty,T. E., Faught,E., Privitera,M. D. (2006. ) Step therapy is not appropriate for antiepileptic drugs .Journal of managed care pharmacy : JMCP, , 12 (3 ) ,269 -70; author reply 270-1

Kent,G. P., Schefft,B. K., Howe,S. R., Szaflarski,J. P., Yeh,H. S., Privitera,M. D. (2006. ) The effects of duration of intractable epilepsy on memory function .Epilepsy & behavior : E&B, , 9 (3 ) ,469 -477

Fargo,J. D., Schefft,B. K., Dulay,M. F., Privitera,M. D., Yeh,H. S. (2005. ) Confrontation naming in individuals with temporal lobe epilepsy: a quantitative analysis of paraphasic error subtypes .Neuropsychology, , 19 (5 ) ,603 -611

Ficker,D. M., Privitera,M., Krauss,G., Kanner,A., Moore,J. L., Glauser,T. (2005. ) Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine .Neurology, , 65 (4 ) ,593 -595

Griffith,N. M., Szaflarski,J. P., Szaflarski,M., Kent,G. P., Schefft,B. K., Howe,S. R., Privitera,M. D. (2005. ) Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II .Epilepsy & behavior : E&B, , 7 (2 ) ,266 -272

Arroyo,S., Dodson,W. E., Privitera,M. D., Glauser,T. A., Naritoku,D. K., Dlugos,D. J., Wang,S., Schwabe,S. K., Twyman,R. E., EPMN-106/INT-28 Investigators (2005. ) Randomized dose-controlled study of topiramate as first-line therapy in epilepsy .Acta Neurologica Scandinavica, , 112 (4 ) ,214 -222

Goldberg-Stern,H., Gadoth,N., Ficker,D., Privitera,M. (2005. ) The effect of age and structural lesions on postictal language impairment .Seizure : the journal of the British Epilepsy Association, , 14 (1 ) ,62 -65

Fargo,J. D., Schefft,B. K., Szaflarski,J. P., Dulay,M. F., Testa,S. M., Privitera,M. D., Yeh,H. S. (2004. ) Accuracy of self-reported neuropsychological functioning in individuals with epileptic or psychogenic nonepileptic seizures .Epilepsy & behavior : E&B, , 5 (2 ) ,143 -150

Privitera,M., Ficker,D. M. (2004. ) Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial .Epilepsy & behavior : E&B, , 5 (6 ) ,841 -846

Szaflarski,J. P., Holland,S. K., Schmithorst,V. J., Dunn,R. S., Privitera,M. D. (2004. ) High-resolution functional MRI at 3T in healthy and epilepsy subjects: hippocampal activation with picture encoding task .Epilepsy & behavior : E&B, , 5 (2 ) ,244 -252

Tang,Y., Lu,A., Ran,R., Aronow,B. J., Schorry,E. K., Hopkin,R. J., Gilbert,D. L., Glauser,T. A., Hershey,A. D., Richtand,N. W., Privitera,M., Dalvi,A., Sahay,A., Szaflarski,J. P., Ficker,D. M., Ratner,N., Sharp,F. R. (2004. ) Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1 .Brain research.Molecular brain research, , 132 (2 ) ,155 -167

Goldberg-Stern,H., Gadoth,N., Cahill,W., Privitera,M. (2004. ) Language dysfunction after frontal lobe partial seizures .Neurology, , 62 (9 ) ,1637 -1638

Cavitt,J., Privitera,M. (2004. ) Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence .Archives of Neurology, , 61 (10 ) ,1604 -1607

Privitera,M. D., Welty,T. (2004. ) Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction .Neurology, , 62 (1 ) ,161; author reply 161

Dulay,M. F., Schefft,B. K., Fargo,J. D., Privitera,M. D., Yeh,H. S. (2004. ) Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy .Epilepsy & behavior : E&B, , 5 (4 ) ,522 -531

Tang,Y., Glauser,T. A., Gilbert,D. L., Hershey,A. D., Privitera,M. D., Ficker,D. M., Szaflarski,J. P., Sharp,F. R. (2004. ) Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study .Acta Neurologica Scandinavica, , 109 (3 ) ,159 -168

Abou-Khalil,B., Hemdal,P., Privitera,M. D. (2003. ) An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy .Seizure : the journal of the British Epilepsy Association, , 12 (3 ) ,141 -149

Privitera,M. D. (2003. ) Phase IV trials: a wolf in sheep';s clothing? .The Annals of Pharmacotherapy, , 37 (5 ) ,741 -743

Schefft,B. K., Marc Testa,S., Dulay,M. F., Privitera,M. D., Yeh,H. S. (2003. ) Preoperative assessment of confrontation naming ability and interictal paraphasia production in unilateral temporal lobe epilepsy .Epilepsy & behavior : E&B, , 4 (2 ) ,161 -168

Szaflarski,J. P., Szaflarski,M., Hughes,C., Ficker,D. M., Cahill,W. T., Privitera,M. D. (2003. ) Psychopathology and quality of life: psychogenic non-epileptic seizures versus epilepsy .Medical science monitor : international medical journal of experimental and clinical research, , 9 (4 ) ,CR113 -8

Szaflarski,J. P., Hughes,C., Szaflarski,M., Ficker,D. M., Cahill,W. T., Li,M., Privitera,M. D. (2003. ) Quality of life in psychogenic nonepileptic seizures .Epilepsia, , 44 (2 ) ,236 -242

Privitera,M. D., Brodie,M. J., Mattson,R. H., Chadwick,D. W., Neto,W., Wang,S., EPMN 105 Study Group (2003. ) Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy .Acta Neurologica Scandinavica, , 107 (3 ) ,165 -175

Welty,T. E., Gidal,B. E., Ficker,D. M., Privitera,M. D. (2002. ) Levetiracetam: a different approach to the pharmacotherapy of epilepsy .The Annals of Pharmacotherapy, , 36 (2 ) ,296 -304

Privitera,M. D., Welty,T. E., Ficker,D. M., Welge,J. (2002. ) Vagus nerve stimulation for partial seizures .Cochrane database of systematic reviews (Online), , (1) (1 ) ,CD002896

Dulay,M. F., Schefft,B. K., Testa,S. M., Fargo,J. D., Privitera,M., Yeh,H. S. (2002. ) What does the family pictures subtest of the Wechsler Memory Scale-III measure? Insight gained from patients evaluated for epilepsy surgery .The Clinical neuropsychologist, , 16 (4 ) ,452 -462

Privitera,M. (2001. ) Efficacy of levetiracetam: a review of three pivotal clinical trials .Epilepsia, , 42 Suppl 4 ,31 -35

Chaisewikul,R., Privitera,M. D., Hutton,J. L., Marson,A. G. (2001. ) Levetiracetam add-on for drug-resistant localization related (partial) epilepsy .Cochrane database of systematic reviews (Online), , (1) (1 ) ,CD001901

Marson,A. G., Hutton,J. L., Leach,J. P., Castillo,S., Schmidt,D., White,S., Chaisewikul,R., Privitera,M., Chadwick,D. W. (2001. ) Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review .Epilepsy research, , 46 (3 ) ,259 -270

Ficker,D. M., Shukla,R., Privitera,M. D. (2001. ) Postictal language dysfunction in complex partial seizures: effect of contralateral ictal spread .Neurology, , 56 (11 ) ,1590 -1592

Privitera,M. D., Yeh,H. S., Blisard,K., Sanchez,N. (2000. ) Detection of epileptogenic focal cortical dysplasia by depth, not subdural electrodes .Neurosurgical review, , 23 (1 ) ,49 -51

Morrell,M. J., McLean,M. J., Willmore,L. J., Privitera,M. D., Faught,R. E., Holmes,G. L., Magnus,L., Bernstein,P., Rose-Legatt (2000. ) Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group .Seizure : the journal of the British Epilepsy Association, , 9 (4 ) ,241 -248

Szaflarski,J. P., Ficker,D. M., Cahill,W. T., Privitera,M. D. (2000. ) Four-year incidence of psychogenic nonepileptic seizures in adults in hamilton county, OH .Neurology, , 55 (10 ) ,1561 -1563

Akimura,T., Yeh,H. S., Mantil,J. C., Privitera,M. D., Gartner,M., Tomsick,T. A. (1999. ) Cerebral metabolism of the remote area after epilepsy surgery .Neurologia medico-chirurgica, , 39 (1 ) ,16 -25; discussion 25-7

Privitera,M. D., Szaflarski,J. P. (1999. ) Complex Partial Seizures in Adults .Current treatment options in neurology, , 1 (4 ) ,323 -338

Fleck,D. E., Berch,D. B., Shear,P. K., Schefft,B. K., Privitera,M. D., Strakowski,S. M. (1999. ) Directed forgetting deficits in patients with temporal lobe epilepsy: an information processing perspective .Journal of the International Neuropsychological Society : JINS, , 5 (6 ) ,549 -555

Privitera,M. D. (1999. ) Evidence-based medicine and antiepileptic drugs .Epilepsia, , 40 Suppl 5 ,S47 -56

Chadwick,D., Privitera,M. (1999. ) Placebo-controlled studies in neurology: where do they stop? .Neurology, , 52 (4 ) ,682 -685

McLean,M. J., Morrell,M. J., Willmore,L. J., Privitera,M. D., Faught,R. E., Holmes,G. L., Magnus-Miller,L., Bernstein,P., Rose-Legatt,A. (1999. ) Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study .Epilepsia, , 40 (7 ) ,965 -972

Gidal,B. E., Privitera,M. D., Sheth,R. D., Gilman,J. T. (1999. ) Vigabatrin: a novel therapy for seizure disorders .The Annals of Pharmacotherapy, , 33 (12 ) ,1277 -1286

Welty,T. E., Privitera,M., Shukla,R. (1998. ) Increased seizure frequency associated with felbamate withdrawal in adults .Archives of Neurology, , 55 (5 ) ,641 -645

Warner,A., Privitera,M., Bates,D. (1998. ) Standards of laboratory practice: antiepileptic drug monitoring. National Academy of Clinical Biochemistry .Clinical chemistry, , 44 (5 ) ,1085 -1095

Kaplan,M., Privitera,M. (1997. ) Affective illness and epilepsy .The Journal of clinical psychiatry, , 58 (11 ) ,498 -499

Privitera,M. (1997. ) Complex partial status epilepticus .Neurology, , 48 (4 ) ,1140 -1141

Rosenfeld,W. E., Sachdeo,R. C., Faught,R. E., Privitera,M. (1997. ) Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment .Epilepsia, , 38 Suppl 1 ,S34 -6

Privitera,M. D. (1997. ) Topiramate: a new antiepileptic drug .The Annals of Pharmacotherapy, , 31 (10 ) ,1164 -1173

Privitera,M., Welty,T. E. (1996. ) Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction .Archives of Neurology, , 53 (11 ) ,1191 -1192

Gidal,B. E., Wagner,M. L., Privitera,M. D., Dalmady-Israel,C., Crismon,M. L., Fagan,S. C., Graves,N. M. (1996. ) Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis .The Annals of Pharmacotherapy, , 30 (11 ) ,1272 -1276

Gidal,B. E., Crismon,M. L., Wagner,M. L., Fagan,S. C., Privitera,M. D., Dalmady-Israel,C., Graves,N. M. (1996. ) Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson';s disease, and stroke .The Annals of Pharmacotherapy, , 30 (12 ) ,1446 -1451

Privitera,M., Kohler,C., Cahill,W., Yeh,H. S. (1996. ) Postictal language dysfunction in patients with right or bilateral hemispheric language localization .Epilepsia, , 37 (10 ) ,936 -941

Arnold,L. M., Privitera,M. D. (1996. ) Psychopathology and trauma in epileptic and psychogenic seizure patients .Psychosomatics, , 37 (5 ) ,438 -443

Privitera,M., Fincham,R., Penry,J., Reife,R., Kramer,L., Pledger,G., Karim,R. (1996. ) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group .Neurology, , 46 (6 ) ,1678 -1683

Privitera,M. (1995. ) Ictal verbal behaviour .Seizure : the journal of the British Epilepsy Association, , 4 (3 ) ,245

Jooma,R., Yeh,H. S., Privitera,M. D., Gartner,M. (1995. ) Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures .Journal of neurosurgery, , 83 (2 ) ,231 -236

Shuren,J. E., Schefft,B. K., Yeh,H. S., Privitera,M. D., Cahill,W. T., Houston,W. (1995. ) Repetition and the arcuate fasciculus .Journal of neurology, , 242 (9 ) ,596 -598

Jooma,R., Yeh,H. S., Privitera,M. D., Rigrish,D., Gartner,M. (1995. ) Seizure control and extent of mesial temporal resection .Acta Neurochirurgica, , 133 (1-2 ) ,44 -49

Privitera,M. D., Treiman,D. M., Pledger,G. W., Sahlroot,J. T., Handforth,A., Linde,M. S., France,C. R., Cereghino,J. J., McCutchen,C. B., Wood,J. H. (1994. ) Dezinamide for partial seizures: results of an n-of-1 design trial .Neurology, , 44 (8 ) ,1453 -1458

Privitera,M., Hoffman,M., Moore,J. L., Jester,D. (1994. ) EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness .Epilepsy research, , 18 (2 ) ,155 -166

Blisard,K. S., Fagin,K., Falivena,P., Privitera,M. D., Olejniczak,P., Harrington,D. A., Taylor,K. L., Scremin,O. U. (1994. ) Experimental seizures in the frog (Rana pipiens) .Epilepsy research, , 17 (1 ) ,13 -22

Privitera,M. D. (1993. ) Clinical rules for phenytoin dosing .The Annals of Pharmacotherapy, , 27 (10 ) ,1169 -1173

Jacobson,G. P., Newman,C. W., Privitera,M., Grayson,A. S. (1991. ) Differences in superficial and deep source contributions to middle latency auditory evoked potential Pa component in normal subjects and patients with neurologic disease .Journal of the American Academy of Audiology, , 2 (1 ) ,7 -17

Privitera,M. D., Morris,G. L., Gilliam,F. (1991. ) Postictal language assessment and lateralization of complex partial seizures .Annals of Neurology, , 30 (3 ) ,391 -396

Yeh,H. S., Privitera,M. D. (1991. ) Secondary epileptogenesis in cerebral arteriovenous malformations .Archives of Neurology, , 48 (11 ) ,1122 -1124

Privitera,M. D., Quinlan,J. G., Yeh,H. S. (1990. ) Interictal spike detection comparing subdural and depth electrodes during electrocorticography .Electroencephalography and clinical neurophysiology, , 76 (5 ) ,379 -387

Liwnicz,B. H., Leach,J. L., Yeh,H. S., Privitera,M. (1990. ) Pericyte degeneration and thickening of basement membranes of cerebral microvessels in complex partial seizures: electron microscopic study of surgically removed tissue .Neurosurgery, , 26 (3 ) ,409 -420

Jacobson,G. P., Privitera,M., Neils,J. R., Grayson,A. S., Yeh,H. S. (1990. ) The effects of anterior temporal lobectomy (ATL) on the middle-latency auditory evoked potential (MLAEP) .Electroencephalography and clinical neurophysiology, , 75 (3 ) ,230 -241

Crutcher,K. A., Privitera,M. (1989. ) Axonal regeneration on mature human brain tissue sections in culture .Annals of Neurology, , 26 (4 ) ,580 -583

Privitera,M. D., Homan,R. W., Ludden,T. M., Peck,C. C., Vasko,M. R. (1989. ) Clinical utility of a Bayesian dosing program for phenytoin .Therapeutic drug monitoring, , 11 (3 ) ,285 -294

Privitera,M. D. (1989. ) Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients .Therapeutic drug monitoring, , 11 (6 ) ,647 -651

Kim, Kwang Ki; Privitera, Michael D; Szaflarski, Jerzy P (2011. ) Lessons learned from a comparison of language localisation using fMRI and electrocortical mapping: case studies of neocortical epilepsy patients.Epileptic disorders : international epilepsy journal with videotape, , 13 (4 ) ,368-74 More Information

Kim, Kwang Ki; Karunanayaka, Prasanna; Privitera, Michael D; Holland, Scott K; Szaflarski, Jerzy P (2011. ) Semantic association investigated with functional MRI and independent component analysis.Epilepsy & behavior : E&B, , 20 (4 ) ,613-22 More Information

Szaflarski, Jerzy P; DiFrancesco, Mark; Hirschauer, Thomas; Banks, Christi; Privitera, Michael D; Gotman, Jean; Holland, Scott K (2010. ) Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI.Epilepsy & behavior : E&B, , 18 (4 ) ,404-13 More Information

Donnelly, Kiely M; Schefft, Bruce K; Howe, Steven R; Szaflarski, Jerzy P; Yeh, Hwa-shain; Privitera, Michael D (2010. ) Moderating effect of optimism on emotional distress and seizure control in adults with temporal lobe epilepsy.Epilepsy & behavior : E&B, , 18 (4 ) ,374-80 More Information

Ramirez, Maya J; Schefft, Bruce K; Howe, Steven R; Hovanitz, Christine; Yeh, Hwa-shain; Privitera, Michael D (2010. ) The effects of perceived emotional distress on language performance in intractable epilepsy.Epilepsy & behavior : E&B, , 18 (1-2 ) ,64-73 More Information

Szaflarski, Jerzy P; Lindsell, Christopher J; Zakaria, Tarek; Banks, Christi; Privitera, Michael D (2010. ) Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.Epilepsy & behavior : E&B, , 17 (4 ) ,525-30 More Information

Black, Leah Chapman; Schefft, Bruce K; Howe, Steven R; Szaflarski, Jerzy P; Yeh, Hwa-shain; Privitera, Michael D (2010. ) The effect of seizures on working memory and executive functioning performance.Epilepsy & behavior : E&B, , 17 (3 ) ,412-9 More Information

Potter, Jennifer Loyden; Schefft, Bruce K; Beebe, Dean W; Howe, Steven R; Yeh, Hwa-Shain; Privitera, Michael D (2009. ) Presurgical neuropsychological testing predicts cognitive and seizure outcomes after anterior temporal lobectomy.Epilepsy & behavior : E&B, , 16 (2 ) ,246-53 More Information

McNally, Kelly A; Schefft, Bruce K; Szaflarski, Jerzy P; Howe, Steven R; Yeh, Hwa-Shain; Privitera, Michael D (2009. ) Application of signal detection theory to verbal memory testing to distinguish patients with psychogenic nonepileptic seizures from patients with epileptic seizures.Epilepsy & behavior : E&B, , 14 (4 ) ,597-603 More Information

Griffith, Nathan M; Smith, Kristen M; Schefft, Bruce K; Szaflarski, Jerzy P; Privitera, Michael D (2008. ) Optimism, pessimism, and neuropsychological performance across semiology-based subtypes of psychogenic nonepileptic seizures.Epilepsy & behavior : E&B, , 13 (3 ) ,478-84 More Information

Privitera, Michael D Generic antiepileptic drugs: current controversies and future directions.Epilepsy currents / American Epilepsy Society, , 8 (5 ) ,113-7 More Information

Schefft, Bruce K; Dulay, Mario F; Fargo, Jamison D; Szaflarski, Jerzy P; Yeh, Hwa-shain; Privitera, Michael D (2008. ) The use of self-generation procedures facilitates verbal memory in individuals with seizure disorders.Epilepsy & behavior : E&B, , 13 (1 ) ,162-8 More Information

Vannest, Jennifer; Szaflarski, Jerzy P; Privitera, Michael D; Schefft, Bruce K; Holland, Scott K (2008. ) Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy.Epilepsy & behavior : E&B, , 12 (3 ) ,410-8 More Information

Fargo, Jamison D; Schefft, Bruce K; Szaflarski, Jerzy P; Howe, Steven R; Yeh, Hwa-Shain; Privitera, Michael D (2008. ) Accuracy of clinical neuropsychological versus statistical prediction in the classification of seizure types.The Clinical neuropsychologist, , 22 (2 ) ,181-94 More Information

Ramirez, Maya J; Schefft, Bruce K; Howe, Steven R; Hwa-Shain, Yeh; Privitera, Michael D (2008. ) Interictal and postictal language testing accurately lateralizes language dominant temporal lobe complex partial seizures.Epilepsia, , 49 (1 ) ,22-32 More Information

Szaflarski, Jerzy P; Holland, Scott K; Jacola, Lisa M; Lindsell, Christopher; Privitera, Michael D; Szaflarski, Magdalena (2008. ) Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy.Epilepsy & behavior : E&B, , 12 (1 ) ,74-83 More Information

Griffith, Nathan M; Szaflarski, Jerzy P; Schefft, Bruce K; Isaradisaikul, David; Meckler, Jason M; McNally, Kelly A; Privitera, Michael D (2007. ) Relationship between semiology of psychogenic nonepileptic seizures and Minnesota Multiphasic Personality Inventory profile.Epilepsy & behavior : E&B, , 11 (1 ) ,105-11 More Information

Fargo, Jamison D; Schefft, Bruce K; Kent, Glenn P; Szaflarski, Jerzy P; Privitera, Michael D; Yeh, Hwa-Shain (2007. ) The prevalence of seizure types among individuals referred for phase I neuropsychological assessment: demographic and neuropsychological characteristics.The Clinical neuropsychologist, , 21 (3 ) ,442-55 More Information

Testa, S Marc; Schefft, Bruce K; Szaflarski, Jerzy P; Yeh, Hwa-Shain; Privitera, Michael D (2007. ) Mood, personality, and health-related quality of life in epileptic and psychogenic seizure disorders.Epilepsia, , 48 (5 ) ,973-82 More Information

Szaflarski, Jerzy P; Meckler, Jason M; Szaflarski, Magdalena; Shutter, Lori A; Privitera, Michael D; Yates, Stephen L (2007. ) Levetiracetam use in critically ill patients.Neurocritical care, , 7 (2 ) ,140-7 More Information

Kent, Glenn P; Schefft, Bruce K; Howe, Steven R; Szaflarski, Jerzy P; Yeh, Hwa-Shain; Privitera, Michael D (2006. ) The effects of duration of intractable epilepsy on memory function.Epilepsy & behavior : E&B, , 9 (3 ) ,469-77 More Information

Szaflarski, Magdalena; Szaflarski, Jerzy P; Privitera, Michael D; Ficker, David M; Horner, Ronnie D (2006. ) Racial/ethnic disparities in the treatment of epilepsy: what do we know? What do we need to know?.Epilepsy & behavior : E&B, , 9 (2 ) ,243-64 More Information

Szaflarski, Magdalena; Meckler, Jason M; Privitera, Michael D; Szaflarski, Jerzy P (2006. ) Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration.Epilepsy & behavior : E&B, , 8 (3 ) ,547-51 More Information

Welty, Timothy E; Faught, Edward; Privitera, Michael D (2006. ) Step therapy is not appropriate for antiepileptic drugs. Journal of managed care pharmacy : JMCP, , 12 (3 ) ,269-70; author reply

Arroyo, S; Dodson, W E; Privitera, M D; Glauser, T A; Naritoku, D K; Dlugos, D J; Wang, S; Schwabe, S K; Twyman, R E (2005. ) Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.Acta neurologica Scandinavica, , 112 (4 ) ,214-22 More Information

Griffith, Nathan M; Szaflarski, Jerzy P; Szaflarski, Magdalena; Kent, Glenn P; Schefft, Bruce K; Howe, Steven R; Privitera, Michael D (2005. ) Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.Epilepsy & behavior : E&B, , 7 (2 ) ,266-72 More Information

Fargo, Jamison D; Schefft, Bruce K; Dulay, Mario F; Privitera, Michael D; Yeh, Hwa-Shain (2005. ) Confrontation naming in individuals with temporal lobe epilepsy: a quantitative analysis of paraphasic error subtypes.Neuropsychology, , 19 (5 ) ,603-11 More Information

Dulay, Mario F; Schefft, Bruce K; Fargo, Jamison D; Privitera, Michael D; Yeh, Hwa-Shain (2004. ) Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy.Epilepsy & behavior : E&B, , 5 (4 ) ,522-31 More Information

Szaflarski, Jerzy P; Holland, Scott K; Schmithorst, Vincent J; Dunn, R Scott; Privitera, Michael D (2004. ) High-resolution functional MRI at 3T in healthy and epilepsy subjects: hippocampal activation with picture encoding task.Epilepsy & behavior : E&B, , 5 (2 ) ,244-52 More Information

Fargo, Jamison D; Schefft, Bruce K; Szaflarski, Jerzy P; Dulay, Mario F; Testa, S Marc; Privitera, Michael D; Yeh, Hwa-Shain (2004. ) Accuracy of self-reported neuropsychological functioning in individuals with epileptic or psychogenic nonepileptic seizures.Epilepsy & behavior : E&B, , 5 (2 ) ,143-50 More Information

Tang, Y; Glauser, T A; Gilbert, D L; Hershey, A D; Privitera, M D; Ficker, D M; Szaflarski, J P; Sharp, F R (2004. ) Valproic acid blood genomic expression patterns in children with epilepsy - a pilot study. Acta neurologica Scandinavica, , 109 (3 ) ,159-68

Privitera, Michael D; Welty, Timothy (2004. ) Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction. Neurology, , 62 (1 ) ,161; author reply 16

Privitera, Michael D (2003. ) Phase IV trials: a wolf in sheep's clothing? .The Annals of pharmacotherapy, , 37 (5 ) ,741-3

Schefft, Bruce K; Marc Testa, S; Dulay, Mario F; Privitera, Michael D; Yeh, Hwa-Shain (2003. ) Preoperative assessment of confrontation naming ability and interictal paraphasia production in unilateral temporal lobe epilepsy. Epilepsy & behavior : E&B, , 4 (2 ) ,161-8

Szaflarski, Jerzy P; Szaflarski, Magdalena; Hughes, Cindy; Ficker, David M; Cahill, William T; Privitera, Michael D (2003. ) Psychopathology and quality of life: psychogenic non-epileptic seizures versus epilepsy. Medical science monitor : international medical journal of experimental and clinical research, , 9 (4 ) ,CR113-8

Abou-Khalil, B; Hemdal, Paula; Privitera, M D (2003. ) An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy. Seizure : the journal of the British Epilepsy Association, , 12 (3 ) ,141-9

Privitera, M D; Brodie, M J; Mattson, R H; Chadwick, D W; Neto, W; Wang, S (2003. ) Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta neurologica Scandinavica, , 107 (3 ) ,165-75

Szaflarski, Jerzy P; Hughes, Cynthia; Szaflarski, Magdalena; Ficker, David M; Cahill, William T; Li, Maureen; Privitera, Michael D (2003. ) Quality of life in psychogenic nonepileptic seizures. Epilepsia, , 44 (2 ) ,236-42

Welty, Timothy E; Gidal, Barry E; Ficker, David M; Privitera, Michael D (2002. ) Levetiracetam: a different approach to the pharmacotherapy of epilepsy. The Annals of pharmacotherapy, , 36 (2 ) ,296-304

Privitera, M D; Welty, T E; Ficker, D M; Welge, J (2002. ) Vagus nerve stimulation for partial seizures.Cochrane database of systematic reviews (Online), , (1 ) ,CD002896 More Information

Ficker, D M; Shukla, R; Privitera, M D (2001. ) Postictal language dysfunction in complex partial seizures: effect of contralateral ictal spread. Neurology, , 56 (11 ) ,1590-2

Chaisewikul, R; Privitera, M D; Hutton, J L; Marson, A G (2001. ) Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.Cochrane database of systematic reviews (Online), , (1 ) ,CD001901 More Information

Szaflarski, J P; Ficker, D M; Cahill, W T; Privitera, M D (2000. ) Four-year incidence of psychogenic nonepileptic seizures in adults in hamilton county, OH. Neurology, , 55 (10 ) ,1561-3

Morrell, M J; McLean, M J; Willmore, L J; Privitera, M D; Faught, R E; Holmes, G L; Magnus, L; Bernstein, P; Rose-Legatt, (2000. ) Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.Seizure : the journal of the British Epilepsy Association, , 9 (4 ) ,241-8 More Information

Privitera, M D; Yeh, H S; Blisard, K; Sanchez, N (2000. ) Detection of epileptogenic focal cortical dysplasia by depth, not subdural electrodes. Neurosurgical review, , 23 (1 ) ,49-51

Gidal, B E; Privitera, M D; Sheth, R D; Gilman, J T (1999. ) Vigabatrin: a novel therapy for seizure disorders. The Annals of pharmacotherapy, , 33 (12 ) ,1277-86

Privitera, ; Szaflarski, (1999. ) Complex Partial Seizures in Adults. Current treatment options in neurology, , 1 (4 ) ,323-338

Fleck, D E; Berch, D B; Shear, P K; Schefft, B K; Privitera, M D; Strakowski, S M (1999. ) Directed forgetting deficits in patients with temporal lobe epilepsy: an information processing perspective. Journal of the International Neuropsychological Society : JINS, , 5 (6 ) ,549-55

McLean, M J; Morrell, M J; Willmore, L J; Privitera, M D; Faught, R E; Holmes, G L; Magnus-Miller, L; Bernstein, P; Rose-Legatt, A (1999. ) Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia, , 40 (7 ) ,965-72

Privitera, M D (1999. ) Evidence-based medicine and antiepileptic drugs. Epilepsia, , 40 Suppl 5 ,S47-56

Akimura, T; Yeh, H S; Mantil, J C; Privitera, M D; Gartner, M; Tomsick, T A (1999. ) Cerebral metabolism of the remote area after epilepsy surgery. Neurologia medico-chirurgica, , 39 (1 ) ,16-25; discussion 25

Privitera, M D (1997. ) Topiramate: a new antiepileptic drug. The Annals of pharmacotherapy, , 31 (10 ) ,1164-73

Gidal, B E; Crismon, M L; Wagner, M L; Fagan, S C; Privitera, M D; Dalmady-Israel, C; Graves, N M (1996. ) Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke. The Annals of pharmacotherapy, , 30 (12 ) ,1446-51

Gidal, B E; Wagner, M L; Privitera, M D; Dalmady-Israel, C; Crismon, M L; Fagan, S C; Graves, N M (1996. ) Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis. The Annals of pharmacotherapy, , 30 (11 ) ,1272-6

Arnold, L M; Privitera, M D Psychopathology and trauma in epileptic and psychogenic seizure patients. Psychosomatics, , 37 (5 ) ,438-43

Shuren, J E; Schefft, B K; Yeh, H S; Privitera, M D; Cahill, W T; Houston, W (1995. ) Repetition and the arcuate fasciculus. Journal of neurology, , 242 (9 ) ,596-8

Jooma, R; Yeh, H S; Privitera, M D; Gartner, M (1995. ) Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures.Journal of neurosurgery, , 83 (2 ) ,231-6 More Information

Jooma, R; Yeh, H S; Privitera, M D; Rigrish, D; Gartner, M (1995. ) Seizure control and extent of mesial temporal resection. Acta neurochirurgica, , 133 (1-2 ) ,44-9

Privitera, M D; Strawsburg, R H (1994. ) Electroencephalographic monitoring in the emergency department. Emergency medicine clinics of North America, , 12 (4 ) ,1089-100

Privitera, M D; Treiman, D M; Pledger, G W; Sahlroot, J T; Handforth, A; Linde, M S; France, C R; Cereghino, J J; McCutchen, C B; Wood, J H (1994. ) Dezinamide for partial seizures: results of an n-of-1 design trial. Neurology, , 44 (8 ) ,1453-8

Blisard, K S; Fagin, K; Falivena, P; Privitera, M D; Olejniczak, P; Harrington, D A; Taylor, K L; Scremin, O U (1994. ) Experimental seizures in the frog (Rana pipiens). Epilepsy research, , 17 (1 ) ,13-22

Privitera, M D (1993. ) Clinical rules for phenytoin dosing. The Annals of pharmacotherapy, , 27 (10 ) ,1169-73

Yeh, H S; Privitera, M D (1991. ) Secondary epileptogenesis in cerebral arteriovenous malformations. Archives of neurology, , 48 (11 ) ,1122-4

Privitera, M D; Morris, G L; Gilliam, F (1991. ) Postictal language assessment and lateralization of complex partial seizures.Annals of neurology, , 30 (3 ) ,391-6 More Information

Privitera, M D; Quinlan, J G; Yeh, H S (1990. ) Interictal spike detection comparing subdural and depth electrodes during electrocorticography. Electroencephalography and clinical neurophysiology, , 76 (5 ) ,379-87

Privitera, M D (1989. ) Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients. Therapeutic drug monitoring, , 11 (6 ) ,647-51

Privitera, M D; Homan, R W; Ludden, T M; Peck, C C; Vasko, M R (1989. ) Clinical utility of a Bayesian dosing program for phenytoin. Therapeutic drug monitoring, , 11 (3 ) ,285-94

Kay, Benjamin P; Holland, Scott K; Privitera, Michael D; Szaflarski, Jerzy P (2014. ) Differences in paracingulate connectivity associated with epileptiform discharges and uncontrolled seizures in genetic generalized epilepsy.Epilepsia, , 55 (2 ) ,256-63 More Information

Knight, William A; Hart, Kimberly W; Adeoye, Opeolu M; Bonomo, Jordan B; Keegan, Shaun P; Ficker, David M; Szaflarski, Jerzy P; Privitera, Michael D; Lindsell, Christopher J (2013. ) The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest.Epilepsy research, , 106 (3 ) ,396-402 More Information

Wilcox, Karen S; Dixon-Salazar, Tracy; Sills, Graeme J; Ben-Menachem, Elinor; White, H Steve; Porter, Roger J; Dichter, Marc A; Moshé, Solomon L; Noebels, Jeffrey L; Privitera, Michael D; Rogawski, Michael A (2013. ) Issues related to development of new antiseizure treatments.Epilepsia, , 54 Suppl 4 ,24-34 More Information

French, Jacqueline A; White, H Steve; Klitgaard, Henrik; Holmes, Gregory L; Privitera, Michael D; Cole, Andrew J; Quay, Ellinor; Wiebe, Samuel; Schmidt, Dieter; Porter, Roger J; Arzimanoglou, Alexis; Trinka, Eugen; Perucca, Emilio (2013. ) Development of new treatment approaches for epilepsy: unmet needs and opportunities.Epilepsia, , 54 Suppl 4 ,3-12 More Information

Kaplan, Marcia J; Dwivedi, Alok K; Privitera, Michael D; Isaacs, Kelly; Hughes, Cynthia; Bowman, Michelle (2013. ) Comparisons of childhood trauma, alexithymia, and defensive styles in patients with psychogenic non-epileptic seizures vs. epilepsy: Implications for the etiology of conversion disorder.Journal of psychosomatic research, , 75 (2 ) ,142-6 More Information

Szaflarski, Jerzy P; Kay, Benjamin; Gotman, Jean; Privitera, Michael D; Holland, Scott K (2013. ) The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate.Epilepsia, , 54 (3 ) ,471-80 More Information

Kay, Benjamin P; DiFrancesco, Mark W; Privitera, Michael D; Gotman, Jean; Holland, Scott K; Szaflarski, Jerzy P (2013. ) Reduced default mode network connectivity in treatment-resistant idiopathic generalized epilepsy.Epilepsia, , 54 (3 ) ,461-70 More Information

Polak, Emily L; Privitera, Michael D; Lipton, Richard B; Haut, Sheryl R (2012. ) Behavioral intervention as an add-on therapy in epilepsy: designing a clinical trial.Epilepsy & behavior : E&B, , 25 (4 ) ,505-10 More Information

Wulsin, Aynara C; Solomon, Matia B; Privitera, Michael D; Danzer, Steve C; Herman, James P (2016. ) Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.Physiology & behavior, , 166 ,22-31 More Information

Privitera, Michael D; Welty, Timothy E; Gidal, Barry E; Diaz, Francisco J; Krebill, Ron; Szaflarski, Jerzy P; Dworetzky, Barbara A; Pollard, John R; Elder, Edmund J; Jiang, Wenlei; Jiang, Xiaohui; Berg, Michel (2016. ) Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.The Lancet. Neurology, , 15 (4 ) ,365-72 More Information

Berg, Michel; Welty, Timothy E; Gidal, Barry E; Diaz, Francisco J; Krebill, Ron; Szaflarski, Jerzy P; Dworetzky, Barbara A; Pollard, John R; Elder, Edmund J; Jiang, Wenlei; Jiang, Xiaohui; Switzer, Regina D; Privitera, Michael D (2017. ) Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.JAMA neurology, , 74 (8 ) ,919-926 More Information

Alsherbini, Khalid A; Plancher, Joao Mc-O?Neil; Ficker, David M; Foreman, Brandon P; Adeoye, Opeolu M; Ying, Jun; Privitera, Michael D (2017. ) Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges in Coma-Incidence and Interrater Reliability of Continuous EEG After a Standard Stimulation Protocol: A Prospective Study.Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, , 34 (4 ) ,375-380 More Information

McKee, Heather R; Privitera, Michael D (2017. ) Stress as a seizure precipitant: Identification, associated factors, and treatment options.Seizure, , 44 ,21-26 More Information

Alsherbini, Khalid A; Metter, E Jeffrey; Foreman, Brandon P; Privitera, Michael D (2019. ) Reply to: Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges in Coma Incidence and Interrater Reliability of Continuous EEG After a Standard Stimulation Protocol; Statistical Issue to Avoid Misdiagnosis and Mismanagement.Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, , 36 (4 ) ,320-321 More Information

1985 Wilder Penfield Fellow for Clinical Epilepsy from Epilepsy Foundation of America for project A Computer Assisted Phenytoin Dosing

1986 Competitive renewal of Wilder Penfield Fellowship for Clinical Epilepsy

1992-1996 Abstract reviewer, American Academy of Neurology, Epilepsy Section

1994 Contributing reviewer, University Hospitals Consortium Drug Monographs

1995 Elected to American Neurological Association

1996 Ad hoc reviewer, Drugs

1997 Co-Chair: American Academy of Neurology section Epilepsy: Antiepileptic Drugs

1997 Ad hoc reviewer: Expert opinion on investigational drugs

1997 Ad hoc reviewer: Medical Letter

1997 Resident teaching award, Department of Neurology

1997-2000 Course Director: Epilepsy I & II at American Academy of Neurology Annual Course

1996-2002 Editor, Epilepsy Quarterly

1991-present Ad hoc reviewer, Electroencephalography and Clinical Neurophysiology

1992-present Ad hoc reviewer, Annals of Pharmacotherapy

1993-present Editorial advisory board, Annals of Pharmacotherapy

1993-present Ad hoc reviewer, Epilepsia, Epilepsy Research, Annals of Neurology, Neurology, Lancet, New England Journal of Medicine, Expert Review of Neurotherapeutics Abstract Reviewer: American Academy of Neurology

2003-present Alpha Omega Alpha (elected)

2003-2008 Best Doctors in America

2004 Business Courier’s Health Care Hero Award

2004 Research proposal reviewer: The Israel Science Foundation

2005 Epilepsy Foundation: “King of Mardi Gras”

2006 National Health Service (UK) Health Technology Assessment Reviewer

2008 Nominated for Doctor’s Day Outstanding Medical Staff Award at University Hospital

1982-present American Academy of Neurology

1984-present American Epilepsy Society

1995-present American Neurological Association

2001-present Academy of Medicine of Cincinnati

2002-present Ohio State Medical Association

Academic - Stetson Building
Suite 2300
Cincinnati  Ohio, 45267-0525
Phone: 513-558-2968
Fax: 513-558-4887
michael.privitera@uc.edu